0001571049-17-004478.txt : 20170504
0001571049-17-004478.hdr.sgml : 20170504
20170504210138
ACCESSION NUMBER: 0001571049-17-004478
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170502
FILED AS OF DATE: 20170504
DATE AS OF CHANGE: 20170504
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: PHIBRO ANIMAL HEALTH CORP
CENTRAL INDEX KEY: 0001069899
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 131840497
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: GLENPOINTE CENTRE EAST, 3RD FLOOR
STREET 2: 300 FRANK W. BURR BLVD., SUITE 21
CITY: TEANECK
STATE: NJ
ZIP: 07666
BUSINESS PHONE: 201-329-7300
MAIL ADDRESS:
STREET 1: GLENPOINTE CENTRE EAST, 3RD FLOOR
STREET 2: 300 FRANK W. BURR BLVD., SUITE 21
CITY: TEANECK
STATE: NJ
ZIP: 07666
FORMER COMPANY:
FORMER CONFORMED NAME: PHILIPP BROTHERS CHEMICALS INC
DATE OF NAME CHANGE: 19980908
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Miller Larry Lee
CENTRAL INDEX KEY: 0001603584
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36410
FILM NUMBER: 17815929
MAIL ADDRESS:
STREET 1: 8 HAZELWOOD COURT
CITY: WARREN
STATE: NJ
ZIP: 07059
FORMER NAME:
FORMER CONFORMED NAME: Miller Larry Lars
DATE OF NAME CHANGE: 20140325
4
1
t1701456_f4.xml
OWNERSHIP DOCUMENT
X0306
4
2017-05-02
0
0001069899
PHIBRO ANIMAL HEALTH CORP
PAHC
0001603584
Miller Larry Lee
300 FRANK W. BURR BLVD., STE 21
TEANECK
NJ
07666-6712
0
1
0
0
Chief Operating Officer
Class A Common Stock
2017-05-02
4
M
0
11969
11.83
A
11969
D
Class A Common Stock
2017-05-02
4
S
0
11969
30.06
D
0
D
Class A Common Stock
2017-05-04
4
M
0
6984
11.83
A
6984
D
Class A Common Stock
2017-05-04
4
S
0
6984
30.26
D
0
D
Option to purchase Class A Common Stock
11.83
2017-05-02
4
M
0
11969
0
D
2013-04-29
2019-02-28
Class A Common Stock
11969
236309
D
Option to purchase Class A Common Stock
11.83
2017-05-04
4
M
0
6984
0
D
2013-04-29
2019-02-28
Class A Common Stock
6984
229325
D
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2016.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.00 to $30.20, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.00 to $30.50, inclusive
/s/ Thomas G. Dagger, as Attorney-in-Fact for Larry L. Miller
2017-05-04